VIA Labs, Inc.

TWSE:6756.TW

169 (TWD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 495.028391.661511.66557.621591.791374.031483.087606.227880.765984.907945.952893.124802.82725.151547.217488.713504.104429.558437.264457.568365.819325.037308.957308.957290.236290.236
Cost of Revenue 279.798279.657325.784309.261313.605194.162244.173291.693411.886461.142435.964407.913375.821352.404288.997252.172251.032216.549218.734222.361174.7148.073154.847154.847151.196151.196
Gross Profit 215.23112.004185.876248.36278.186179.869238.914314.534468.879523.765509.988485.211426.999372.747258.22236.541253.072213.009218.53235.207191.119176.964154.111154.111139.041139.041
Gross Profit Ratio 0.4350.2860.3630.4450.470.4810.4950.5190.5320.5320.5390.5430.5320.5140.4720.4840.5020.4960.50.5140.5220.5440.4990.4990.4790.479
Reseach & Development Expenses 122.567116.835125.678153.071178.959148.845159.509179.347176.423199.471194.205172.961147.821135.78123.301116.389137.435110.64101.997129.985107.401112.881101.024101.02495.98295.982
General & Administrative Expenses 16.84317.16121.7222.78117.70214.05222.25216.65617.83516.63716.86916.75313.90712.35313.31711.57111.2879.90112.2968.3769.138.3367.4337.4336.6846.684
Selling & Marketing Expenses 23.87812.42712.00216.20412.38612.7466.31513.6612.52615.25316.21412.27410.88212.78211.33810.5996.38312.68914.34611.71913.22210.82611.8611.867.1227.122
SG&A 40.72129.58833.72238.98530.08826.79828.56730.31630.36131.8933.08329.02724.78925.13524.65522.1717.6722.5926.64220.09522.35219.16219.59419.59414.66614.666
Other Expenses -2.69562.349-27.1727.69117.1516.151-22.01154.38339.37349.60514.7742.622-11.418-1.503-15.402-11.226-10.3346.5-3.7510.7753.8174.2530000
Operating Expenses 163.288146.423159.4192.056209.047175.643188.076209.663206.784231.361227.288201.988172.61160.915147.956138.559155.105133.23128.639150.08129.753132.043124.847124.847110.265110.265
Operating Income 51.942-34.41926.47692.3595.29417.96536.653163.926304.204344.225297.894288.446245.607212.40495.3787.49489.03886.27978.5688.24467.87449.17434.12634.12629.32229.322
Operating Income Ratio 0.105-0.0880.0520.1660.1610.0480.0760.270.3450.350.3150.3230.3060.2930.1740.1790.1770.2010.180.1930.1860.1510.110.110.1010.101
Total Other Income Expenses Net 6.17287.906-18.147-0.023-0.037-0.051-0.437-0.079-0.374-0.106-1.419-0.306-0.292-0.984-0.023-0.036-0.087-0.378-0.149-0.429-0.106-0.826-2.529-2.5291.0491.049
Income Before Tax 58.11453.4878.32992.32795.25717.91436.216163.847303.83344.119296.475288.14245.315211.4295.34787.45888.95185.90178.41187.81567.76848.34831.59731.59730.37130.371
Income Before Tax Ratio 0.1170.1370.0160.1660.1610.0480.0750.270.3450.3490.3130.3230.3060.2920.1740.1790.1760.20.1790.1920.1850.1490.1020.1020.1050.105
Income Tax Expense 5.8052.491-0.45314.96315.882.868-5.74626.34248.7355.15149.10747.73737.64926.54611.5829.3696.75111.47115.64412.9385.4235.5180.4550.4550.4440.444
Net Income 52.27250.9968.78277.36479.37715.04641.962137.505255.1288.968247.368240.403207.666184.87483.76578.08982.274.4362.76774.87762.34542.8331.14231.14230.81430.814
Net Income Ratio 0.1060.130.0170.1390.1340.040.0870.2270.290.2930.2620.2690.2590.2550.1530.160.1630.1730.1440.1640.170.1320.1010.1010.1060.106
EPS 0.750.730.131.121.150.220.612.013.724.233.663.563.082.741.391.31.371.241.051.251.040.710.50.50.510.51
EPS Diluted 0.740.720.131.11.130.210.611.943.614.093.663.412.952.621.391.241.311.181.051.21.010.690.50.50.510.51
EBITDA 99.92110.28665.545127.318127.79751.30774.255197.349335.189372.138318.389307.375261.36225.995110.41998.99199.47894.4386.05694.10373.65155.34936.16436.16431.11631.116
EBITDA Ratio 0.2020.0260.1280.2280.2160.1370.1540.3260.3810.3780.3370.3440.3260.3120.2020.2030.1970.220.1970.2060.2010.170.1170.1170.1070.107